- Predictmedix is partnering with Aspen Properties and Juiceworks Exhibits in Calgary in Edmonton to install its Safe Entry Stations at four downtown office towers
- The two-year contract will allow the buildings to provide voluntary screening for infectious disease symptoms
- Predictmedix is engaged in the development of medical devices using artificial intelligence
- Predictmedix (PMED) opened trading at $0.42 per share
Predictmedix, in partnership with Aspen Properties and Juiceworks Exhibits, is deploying Safe Energy Stations at four downtown office towers in Calgary & Edmonton.
Predictmedix has worked previously with Juiceworks to implement the Safe Entry Stations in other locations across the country.
The two-year contract will allow the buildings to “raise the bar” by providing a completely voluntary infectious disease symptom screening option for their tenants.
Dr. Rahul Kushwah of Predictmedix commented,
“We are excited to partner with Aspen Properties as they are a large property management company in Western Canada and are seen as true visionaries in the industry.
“These deployments pave the way for our further expansion into the commercial real estate sector and being the high-profile locations these are, they offer us great visibility and a unique opportunity to showcase our cutting edge technologies.”
Predictmedix’s Safe Entry Stations use artificial intelligence and multi-spectral cameras to scan and detect a variety of infectious disease symptoms.
The technology is non-invasive, expediting the screening process even at high volume locations.
R. Scott Hutcheson, Executive Chair of Aspen Properties, also commented on the partnership.
“This form of high volume symptom screening has added an innovative tool to our properties, and offers peace of mind to our tenants and guests in these uncertain times,” he said.
The new Safe Entry Stations will be installed at Calgary’s The Edison, Palliser Complex, and The Ampersand and Edmonton’s Bell Tower.
Predictmedix is engaged in the development of medical devices using artificial intelligence.
Its partner, Juiceworks, is acknowledged by clients globally as the go-to supplier for innovative design, quality craftsmanship and production.
Predictmedix (PMED) opened trading at $0.42 per share.